The company said it is bullish about the branded generics biz & is ‘open to partnerships with local cos that will help it ‘provide high-qua...

In a letter, US pharma giant Pfizer has urged the Indian government to “shift from using destructive IP policy as an access strategy”.

Indian Pharma Alliance (IPA) writes to Roy Waldron after he slammed country's IP policy as protectionist and discriminatory.

If a country feels that a provision or policy of another nation discriminates against its companies, it can challenge that under WTO's disp...

Patent experts say few drugmakers are challenging frivolous drug patents and the Indian patent office is actually liberal in granting paten...

India exported medicines worth $13.2 billion last fiscal and the government plans to double it to $25 billion by March 2014.

Sun Pharma said US-based Wyeth Pharma has sought damages worth $960 mn related to their ongoing patent dispute over generic version of Prot...

The approval marks an end to months of uncertainty surrounding approval of the drug which could earn Ranbaxy over $500 mn. Stock quote

"The FDA has been very positive about Ranbaxy's intent to launch the product and we are working towards meeting the launch timeline", a per...

US-based Watson Pharmaceuticals said it has launched in US market the generic version of cholesterol lowering drug Lipitor following the ex...

India's attempts to check foreign investment in pharma and expand drug pricing control could force multinationals to exit the country.

Pfizer's Lipitor is the world's largest-selling drug, which generated about $7 billion in sales last year in the US alone.

Settling the issue is of immense importance to Ranbaxy as it is the first firm to file an abbreviated new drug application to launch a gene...

Several global drugmakers, including Pfizer, Roche and Bayer, have not met full mandatory disclosures of their patented medicines in India,...

A legal battle between Pfizer and Sun Pharmaceutical has escalated.

The government has asked MNC pharma companies to launch latest drugs in India.

In yet another boost to India's biggest drug maker Ranbaxy Laboratories, a Norwegian court has ruled in its favour in the patent litigation...